Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset

Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset

Submitted by admin on November 28, 2018 - 11:51am
Source: 
BioSpace
News Tags: 
M&A
Coeptis Pharmaceuticals
Elto Pharma
Amarantus BioSciences
Parkinson's Disease
Headline: 
Coeptis Pharma Buys Elto Pharma for Phase II Parkinson's Asset
snippet: 

Wexford, Pa.-based Coeptis Pharmaceuticals is buying New York-based Elto Pharma. Elto Pharma is a joint venture between Amarantus Bioscience Holdings and PsychoGenics.

Do Not Allow Advertisers to Use My Personal information